Cargando…

COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States

On 17 June 2022, the U.S. FDA authorized the Pfizer-BioNTech and Moderna COVID-19 (SARS-CoV-2) vaccines for emergency use (EUA) in children ages 6 months–4 years. Seroprevalence has increased during the current Omicron variant wave for children under 5 years, and the burden of hospitalization for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Celia B., Bragard, Elise, Jaber, Rimah, Gray, Aaliyah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413913/
https://www.ncbi.nlm.nih.gov/pubmed/36016200
http://dx.doi.org/10.3390/vaccines10081313
_version_ 1784775867096891392
author Fisher, Celia B.
Bragard, Elise
Jaber, Rimah
Gray, Aaliyah
author_facet Fisher, Celia B.
Bragard, Elise
Jaber, Rimah
Gray, Aaliyah
author_sort Fisher, Celia B.
collection PubMed
description On 17 June 2022, the U.S. FDA authorized the Pfizer-BioNTech and Moderna COVID-19 (SARS-CoV-2) vaccines for emergency use (EUA) in children ages 6 months–4 years. Seroprevalence has increased during the current Omicron variant wave for children under 5 years, and the burden of hospitalization for this age group is similar or exceeds other pediatric vaccine-preventable diseases. Research following the October 2021 EUA for vaccines for children 5–11 indicates a high prevalence of parental vaccine hesitancy and low uptake, underscoring the urgency of understanding attitudes and beliefs driving parental COVID-19 vaccine rejection and acceptance for younger children. One month prior to FDA approval, in the present study 411 U.S. female guardians of children 1–4 years from diverse racial/ethnic, economic, and geographic backgrounds participated in a mixed method online survey assessing determinants of COVID-19 pediatric vaccine hesitancy. Only 31.3% of parents intended to vaccinate their child, 22.6% were unsure, and 46.2% intended not to vaccinate. Logistic regression indicated significant barriers to vaccination uptake including concerns about immediate and long-term vaccination side effects for young children, the rushed nature of FDA approval and distrust in government and pharmaceutical companies, lack of community and family support for pediatric vaccination, conflicting media messaging, and lower socioeconomic status. Vaccine-resistant and unsure parents were also more likely to believe that children were not susceptible to infection and that the vaccine no longer worked against new variants. Findings underscore the need for improved public health messaging and transparency regarding vaccine development and approval, the importance of community outreach, and increased pediatrician attention to parental concerns to better improve COVID-19 vaccine uptake for young children.
format Online
Article
Text
id pubmed-9413913
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94139132022-08-27 COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States Fisher, Celia B. Bragard, Elise Jaber, Rimah Gray, Aaliyah Vaccines (Basel) Article On 17 June 2022, the U.S. FDA authorized the Pfizer-BioNTech and Moderna COVID-19 (SARS-CoV-2) vaccines for emergency use (EUA) in children ages 6 months–4 years. Seroprevalence has increased during the current Omicron variant wave for children under 5 years, and the burden of hospitalization for this age group is similar or exceeds other pediatric vaccine-preventable diseases. Research following the October 2021 EUA for vaccines for children 5–11 indicates a high prevalence of parental vaccine hesitancy and low uptake, underscoring the urgency of understanding attitudes and beliefs driving parental COVID-19 vaccine rejection and acceptance for younger children. One month prior to FDA approval, in the present study 411 U.S. female guardians of children 1–4 years from diverse racial/ethnic, economic, and geographic backgrounds participated in a mixed method online survey assessing determinants of COVID-19 pediatric vaccine hesitancy. Only 31.3% of parents intended to vaccinate their child, 22.6% were unsure, and 46.2% intended not to vaccinate. Logistic regression indicated significant barriers to vaccination uptake including concerns about immediate and long-term vaccination side effects for young children, the rushed nature of FDA approval and distrust in government and pharmaceutical companies, lack of community and family support for pediatric vaccination, conflicting media messaging, and lower socioeconomic status. Vaccine-resistant and unsure parents were also more likely to believe that children were not susceptible to infection and that the vaccine no longer worked against new variants. Findings underscore the need for improved public health messaging and transparency regarding vaccine development and approval, the importance of community outreach, and increased pediatrician attention to parental concerns to better improve COVID-19 vaccine uptake for young children. MDPI 2022-08-14 /pmc/articles/PMC9413913/ /pubmed/36016200 http://dx.doi.org/10.3390/vaccines10081313 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fisher, Celia B.
Bragard, Elise
Jaber, Rimah
Gray, Aaliyah
COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States
title COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States
title_full COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States
title_fullStr COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States
title_full_unstemmed COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States
title_short COVID-19 Vaccine Hesitancy among Parents of Children under Five Years in the United States
title_sort covid-19 vaccine hesitancy among parents of children under five years in the united states
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413913/
https://www.ncbi.nlm.nih.gov/pubmed/36016200
http://dx.doi.org/10.3390/vaccines10081313
work_keys_str_mv AT fisherceliab covid19vaccinehesitancyamongparentsofchildrenunderfiveyearsintheunitedstates
AT bragardelise covid19vaccinehesitancyamongparentsofchildrenunderfiveyearsintheunitedstates
AT jaberrimah covid19vaccinehesitancyamongparentsofchildrenunderfiveyearsintheunitedstates
AT grayaaliyah covid19vaccinehesitancyamongparentsofchildrenunderfiveyearsintheunitedstates